Page last updated: 2024-09-05

sb 203580 and gentiopicroside

sb 203580 has been researched along with gentiopicroside in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(gentiopicroside)
Trials
(gentiopicroside)
Recent Studies (post-2010) (gentiopicroside)
3,48941,1371740120

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, Y; Mu, F; Wu, H; You, Q; Zhang, N1

Other Studies

1 other study(ies) available for sb 203580 and gentiopicroside

ArticleYear
Gentiopicrin exerts anti-rheumatic effect in human fibroblast-like synoviocytes via inhibition of p38MAPK/NF-κB pathway.
    Cellular and molecular biology (Noisy-le-Grand, France), 2019, Aug-05, Volume: 65, Issue:6

    Topics: Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Fibroblasts; Humans; Imidazoles; Interleukin-1beta; Interleukin-6; Iridoid Glucosides; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Pyridines; RNA, Messenger; Signal Transduction; Sulfones; Synoviocytes; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2019